Announcement • Apr 29
Serge Ferrari Group Discontinues Pet Spinning Operations At Tersuisse Site and Reduces 62 Jobs Serge Ferrari Group announced a new phase in the rollout of its plan to streamline its industrial operations, with plans to cease operations at the Tersuisse site, its high-tenacity PET (polyethylene terephthalate) yarn production plant located in Emmenbrücke, Switzerland, which employs 62 people. Industrial continuity would be fully ensured through external supplies of PET yarn. The Group would, however, retain the intellectual property and technological expertise related to its specialty yarns. Warping operations would be transferred to the La Tour du Pin site to secure the value chain and keep key expertise at the heart of the industrial infrastructure. In line with its strategic plan, this project aims to strengthen the Group’s competitiveness and industrial flexibility to better address the accelerating pace of change in its business segments. It would result in exceptional expenses in the first half of 2026, with a limited cash impact, but would have a positive effect on operating profitability while reducing capital employed starting in 2027. Announcement • Apr 23
SergeFerrari Group SA to Report First Half, 2026 Results on Sep 09, 2026 SergeFerrari Group SA announced that they will report first half, 2026 results on Sep 09, 2026 New Risk • Apr 10
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risk Market cap is less than US$100m (€79.1m market cap, or US$92.5m). Reported Earnings • Mar 29
Full year 2025 earnings released: EPS: €0.47 (vs €1.31 loss in FY 2024) Full year 2025 results: EPS: €0.47 (up from €1.31 loss in FY 2024). Revenue: €347.5m (up 7.4% from FY 2024). Net income: €5.36m (up €20.5m from FY 2024). Profit margin: 1.5% (up from net loss in FY 2024). Revenue is forecast to grow 3.9% p.a. on average during the next 2 years, compared to a 10% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance. New Risk • Mar 27
New major risk - Revenue and earnings growth Earnings have declined by 45% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.2x net interest cover). Earnings have declined by 45% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (€80.0m market cap, or US$92.1m). Announcement • Mar 14
SergeFerrari Group SA announces Annual dividend, payable on June 04, 2026 SergeFerrari Group SA announced Annual dividend of EUR 0.1300 per share payable on June 04, 2026, ex-date on June 02, 2026 and record date on June 03, 2026. New Risk • Mar 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of British stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Market cap is less than US$100m (€73.1m market cap, or US$83.5m). Announcement • Mar 14
SergeFerrari Group SA, Annual General Meeting, Apr 22, 2026 SergeFerrari Group SA, Annual General Meeting, Apr 22, 2026. Location: zi de la tour du pin, saint jean de soudain France New Risk • Mar 09
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €82.5m (US$95.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risk Market cap is less than US$100m (€82.5m market cap, or US$95.8m). Announcement • Oct 21
SergeFerrari Group SA to Report Fiscal Year 2025 Results on Mar 11, 2026 SergeFerrari Group SA announced that they will report fiscal year 2025 results After-Market on Mar 11, 2026 New Risk • Sep 13
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 2.2x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.2x net interest cover). Shares are highly illiquid. Minor Risk Market cap is less than US$100m (€78.1m market cap, or US$91.6m). Announcement • Apr 25
SergeFerrari Group SA to Report First Half, 2025 Results on Sep 10, 2025 SergeFerrari Group SA announced that they will report first half, 2025 results on Sep 10, 2025 Reported Earnings • Apr 04
Full year 2024 earnings released: €1.31 loss per share (vs €0.40 profit in FY 2023) Full year 2024 results: €1.31 loss per share (down from €0.40 profit in FY 2023). Revenue: €323.6m (down 1.2% from FY 2023). Net loss: €15.2m (down 422% from profit in FY 2023). Revenue is forecast to grow 4.3% p.a. on average during the next 2 years, compared to a 2.5% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. Announcement • Mar 29
SergeFerrari Group SA, Annual General Meeting, May 15, 2025 SergeFerrari Group SA, Annual General Meeting, May 15, 2025. Buy Or Sell Opportunity • Mar 28
Now 25% undervalued The stock has been flat over the last 90 days, currently trading at €5.41. The fair value is estimated to be €7.18, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 4.3% in a year. Earnings are forecast to grow by 87% in the next year. Announcement • Oct 31
SergeFerrari Group SA to Report Fiscal Year 2024 Results on Mar 27, 2025 SergeFerrari Group SA announced that they will report fiscal year 2024 results on Mar 27, 2025 Upcoming Dividend • Jun 21
Upcoming dividend of €0.12 per share Eligible shareholders must have bought the stock before 28 June 2024. Payment date: 02 July 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of British dividend payers (5.6%). Lower than average of industry peers (3.3%). Valuation Update With 7 Day Price Move • May 10
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €7.38, the stock trades at a forward P/E ratio of 33x. Average forward P/E is 5x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.81 per share. New Risk • Mar 31
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 48% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.1x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.4% net profit margin). Market cap is less than US$100m (€69.2m market cap, or US$74.6m). Reported Earnings • Mar 29
Full year 2023 earnings released: EPS: €0.40 (vs €1.30 in FY 2022) Full year 2023 results: EPS: €0.40 (down from €1.30 in FY 2022). Revenue: €327.6m (down 3.3% from FY 2022). Net income: €4.72m (down 70% from FY 2022). Profit margin: 1.4% (down from 4.6% in FY 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom. Announcement • Mar 27
SergeFerrari Group SA Proposes Dividend for Fiscal Year 2023, Payable in July 2024 SergeFerrari Group SA announced that, at the Annual General Meeting of May 16th, 2024, the Group will propose a dividend of €0.12 per share for fiscal year 2023, payable in July 2024. Announcement • Jan 31
SergeFerrari Group SA to Report Fiscal Year 2023 Results on Mar 26, 2024 SergeFerrari Group SA announced that they will report fiscal year 2023 results After-Market on Mar 26, 2024 Valuation Update With 7 Day Price Move • Jan 25
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €6.50, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €12.45 per share. New Risk • Dec 07
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 1.7% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Earnings are forecast to decline by an average of 1.7% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (139% cash payout ratio). Share price has been volatile over the past 3 months (9.6% average weekly change). Valuation Update With 7 Day Price Move • Nov 21
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to €7.47, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 29% over the past year. Valuation Update With 7 Day Price Move • Nov 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to €6.25, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 38% over the past year. Valuation Update With 7 Day Price Move • Oct 19
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to €6.29, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 38% over the past year. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €8.15, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total loss to shareholders of 15% over the past year. Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to €12.10, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 109% over the past three years. Upcoming Dividend • Apr 19
Upcoming dividend of €0.40 per share at 2.8% yield Eligible shareholders must have bought the stock before 26 April 2023. Payment date: 28 April 2023. Payout ratio is a comfortable 31% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%). Reported Earnings • Mar 07
Full year 2022 earnings released: EPS: €1.30 (vs €0.86 in FY 2021) Full year 2022 results: EPS: €1.30 (up from €0.86 in FY 2021). Revenue: €338.7m (up 19% from FY 2021). Net income: €15.5m (up 53% from FY 2021). Profit margin: 4.6% (up from 3.6% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 1.3% growth forecast for the Chemicals industry in the United Kingdom. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 15% share price gain to €13.30, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 8.8% over the past year. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €9.63, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment deteriorated over the past week After last week's 18% share price decline to €12.78, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 89% over the past year. Upcoming Dividend • May 12
Upcoming dividend of €0.29 per share Eligible shareholders must have bought the stock before 19 May 2022. Payment date: 23 May 2022. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of British dividend payers (4.8%). Lower than average of industry peers (2.7%). Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improved over the past week After last week's 15% share price gain to €16.52, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Simply Wall St's valuation model estimates the intrinsic value at €14.13 per share. Reported Earnings • Mar 09
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: €0.86 (up from €0.04 in FY 2020). Revenue: €285.9m (up 46% from FY 2020). Net income: €10.2m (up €9.71m from FY 2020). Profit margin: 3.6% (up from 0.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Over the next year, revenue is forecast to grow 8.8% compared to a 12% decline forecast for the industry in the United Kingdom. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment improved over the past week After last week's 19% share price gain to €14.84, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improved over the past week After last week's 36% share price gain to €9.09, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Simply Wall St's valuation model estimates the intrinsic value at €16.73 per share.